| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Interview Perspectives - The Interviewer Who Wouldn't Interview |
|
Advice You - Interview Perspectives - The Interviewer Who Wouldn't Interview
In my practice I’ve come across all sorts of interview feedback from my clients, but this stands out as being worthy of b According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ringing to your attention. With all of my clients we cover the importance of interview preparation; knowing what you hav ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e to offer and being able to discuss why you want the job and are the most suitable candidate. In addition having the con lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. fidence to conduct the interview on an equal footing with the interviewer so you can make your decision about whether the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe job is right for you. All of this depends on actually taking part in the interview of course and if the interviewer – t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hrough incompetence or other reason – doesn’t allow that, what can you do? The story is about the interviewer who sent m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y client, Chuck, away without any discussion whatsoever. When Chuck returned, he was really down. “I did everything rig easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ht and I know I am the best person for this particular Field Sales role, but he just wouldn’t talk to me, and sent me awa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically y; what a waste of time!” What happened was that when Chuck was shown into the interview room, the Field Sales Director and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ barely looked up from what he was writing and just said: “Thanks for coming – you’re not what we want, check with the de ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sk for your travel expenses, goodbye.” Most firms don’t intentionally waste your time, so you have to ask yourself what ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a is going on. What happened here was the Field Sales Director’s way of putting Chuck to an immediate test – how would he dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod react at being rejected? Rejection is the greatest problem for Field Sales people to overcome, but Chuck never expected cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to encounter it at his interview. When I got Chuck to think about this he realised that he should have applied his sales tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen skills to the situation to find out if there really was a problem. So what he should have done was ask “What is it abou t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t me that makes you think I’m not right for the job?” This way if there was a genuine problem he would have the chance t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o deal with it, or if it was just a test he would have passed the first stage. This is generally known as ‘objection sell y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ing’ and is a powerful technique. First identify if there is a real problem (objection) and then you have the opportunit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y to minimise it or make it go away altogether. In this case Chuck would then be able to offer up some solid reasons why elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip he was right for the job. And once he got started he would be on the way to securing the job he knew was right for him. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Macintosh: Apples for Businessmen Is This Field for You? 5 Career Factors to Consider Your Best Weapon in a Job Hunting Campaign: The Cover Letter
|